Effects of rosiglitazone and sulphonylureas on ischaemic burden, blood pressure, and novel risk markers inclusive of vascular function in patients with chronic stable angina and type 2 diabetes mellitus: a randomised, double-blinded st...
Phase of Trial: Phase II
Latest Information Update: 24 Feb 2010
At a glance
- Drugs Rosiglitazone; Sulfonylureas
- Indications Angina pectoris; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 15 Jul 2005 New trial record.